Speakers

Adrian Sanborn

Founding Scientist & Bioscience Lead

ATOMIC AI

Amanda Hargrove

Professor of Chemistry

Duke University

Andrew Krueger

Research Investigator

Novartis

Aneesh Acharya Speaker Headshot

Aneesh Acharya

Vice President of Commerical

Molecular Instruments

Anu Bhattacharyya

Vice President

PTC Therapeutics

Balajee Somalinga

Director - RNA Biology

CHDI Foundation

Dominic Reynolds

Senior Vice President of Drug Discovery,

Remix Therapeutics

Dr. Peter Rye

VP, Application Development

Momentum Biotechnologies

Eric Westhof

Professor

Institut de biologie moléculaire et cellulaire du CNRS, Université de Strasbourg, France

Franz Obermayr

Chief Executive Officer

EPICS Therapeutics

Haishan Xiong

Chief Executive Officer

Panorama Medicine

Hashim Al-Hashimi

Co-Founder, Platform Architect

Base4 Biotechnology

Irina Tuszynska

Group & Bioinformatics Lead

Molecure

Isaac Kimsey

Vice President of Drug Discovery

Base4 Biotechnology

Jackie Salotti

Principal Scientist

ReviR Therapeutics

Jennifer Petter

Founder & Chief Innovation Officer

Arrakis Therapeutics Inc.

Jenny Wang

Director of search and evaluation for oncology

Abbvie

Applied biomath - logo

Joshua Apgar

Co-founder & Chief Scientific Officer

Applied BioMath

Katie Warner

Co-founder and VP of RNA Biology

Ribometrix

Kevin Guckian Speaker Headshot

Kevin Guckian

Senior Director

Biogen

Kimberly Robasky

AD ML/AI

Arrakis Therapeutics

Li Zhang

Director, Quantitative Clinical Pharmacology

Daiichi Sankyo

Mark Ledeboer

Senior Vice President - Drug Discovery

Expansion Therapeutics

Martina Roos

CEO, Co-Founder, President

Sardona Therapeutics

Matt Disney

Institute Professor & Chair of Chemistry

The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology

Matt Woll

Vice President, Chemistry

PTC Therapeutics

Matthew Daniels

Associate Director

Accent Therapeutics

Matthew Jones

Head Of Platform Technology

NextRNA Therapeutics

Pascale Beurdeley

Senior Vice President of Product Development

Depixus SAS

Peng Yue

Co-Founder & Chief Executive Officer

ReviR Therapeutics

Peter Smith

Co-Founder, President & Chief Executive Officer

Remix Therapeutics

Quentin Vicens

Assistant Professor

University of Houston

Sarah Duellman

Global Strategic Business Lead - Biotech

Promega Corporation

Shunnichi Kashida

Co-Founder, Representative Director, President & Chief Executive Officer

Officer xFOREST Therapeutics

Simon Xi

Co-Founder and Chief Executive officer

Rgenta Therapeutics

Sridar Narayan Speaker Headshot

Sridhar Narayan

Vice President

ReviR Therapeutics

Tamara Reyes Robles

Principal Scientist

Ananke Therapeutics

Tom Chappie

Senior Principal Scientist & Associate Fellow, Research

Pfizer

Yochi Slonim

Co-founder & CEO

Anima Biotech

REGISTER
PRE-CONFERENCE WORKSHOP DAY